{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:57:50Z","timestamp":1770818270133,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The introduction of noninvasive prenatal screening (NIPS) using cell-free DNA (cfDNA) is the newest option for aneuploidy screening during pregnancy. Compared with other aneuploidy screening options, NIPS offers a higher detection rate for trisomy 21 with a low false-positive rate. However, pretest and post-test patient counseling is essential and should include a discussion of the benefits and limitations, the screening rather than diagnostic nature of the test, and the association of a test failure with an increased risk of aneuploidy. Refer patients for genetic counseling when appropriate, particularly if test failure occurs due to a low fetal fraction or if maternal mosaicism or malignancy is suspected.<\/jats:p>","DOI":"10.1097\/01.jaa.0000654208.03441.23","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T23:02:11Z","timestamp":1585263731000},"page":"49-53","source":"Crossref","is-referenced-by-count":6,"title":["Benefits and limitations of noninvasive prenatal aneuploidy screening"],"prefix":"10.1097","volume":"33","author":[{"given":"David Eric","family":"Abel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Alagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"7","key":"R1-20230817","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230817","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.12688\/f1000research.9215.1","article-title":"Recent advances in prenatal genetic screening and testing","volume":"5","author":"Van den Veyver","year":"2016","journal-title":"F1000Res"},{"issue":"9076","key":"R4-20230817","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"R5-20230817","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"issue":"1","key":"R6-20230817","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"issue":"1","key":"R7-20230817","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"9","key":"R8-20230817","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.earlhumdev.2006.11.001","article-title":"Early detection of cell-free fetal DNA in maternal plasma","volume":"83","author":"Illanes","year":"2007","journal-title":"Early Hum Dev"},{"issue":"7","key":"R10-20230817","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4119","article-title":"Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma","volume":"33","author":"Wang","year":"2013","journal-title":"Prenat Diagn"},{"issue":"8","key":"R11-20230817","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pd.4625","article-title":"Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing","volume":"35","author":"Kinnings","year":"2015","journal-title":"Prenat Diagn"},{"key":"R12-20230817","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"R13-20230817","doi-asserted-by":"crossref","first-page":"413.e1","DOI":"10.1016\/j.ajog.2017.01.011","article-title":"Obesity and cell-free DNA \u201cno calls\u201d: is there an optimal gestational age at time of sampling","volume":"216","author":"Livergood","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"R14-20230817","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/uog.17492","article-title":"cfDNA screening performance: accounting for and reducing test failures","volume":"49","author":"Cuckle","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"R15-20230817","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jhg.2016.25","article-title":"Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy","volume":"61","author":"Suzumori","year":"2016","journal-title":"J Hum Genet"},{"issue":"2","key":"R16-20230817","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/14767058.2012.722731","article-title":"The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy","volume":"26","author":"Brar","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"R17-20230817","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"R18-20230817","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.semperi.2015.11.006","article-title":"Screening for fetal aneuploidy","volume":"40","author":"Rink","year":"2016","journal-title":"Semin Perinatol"},{"issue":"5","key":"R19-20230817","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000000452","article-title":"Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing","volume":"124","author":"Norton","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"10","key":"R22-20230817","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/pd.4601","article-title":"Overview of the impact of noninvasive prenatal testing on diagnostic procedures","volume":"35","author":"Warsof","year":"2015","journal-title":"Prenat Diagn"},{"issue":"8","key":"R23-20230817","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/pd.4608","article-title":"Position statement from the chromosome abnormality screening committee on behalf of the board of the international society for prenatal diagnosis","volume":"35","author":"Benn","year":"2015","journal-title":"Prenat Diagn"},{"issue":"2","key":"R24-20230817","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.siny.2017.10.006","article-title":"Screening for fetal chromosomal and subchromosomal disorders","volume":"23","author":"Harris","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"R25-20230817","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pd.4541","article-title":"Circulating cell free DNA testing: are some test failures informative","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat Diagn"},{"issue":"1","key":"R26-20230817","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/uog.14664","article-title":"Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10\u201311 weeks' gestation and the combined test at 11-13 weeks","volume":"45","author":"Quezada","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"R27-20230817","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"R28-20230817","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"11","key":"R29-20230817","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pd.4668","article-title":"The influence of low molecular weight heparin medication on plasma DNA in pregnant women","volume":"35","author":"Gr\u00f6mminger","year":"2015","journal-title":"Prenat Diagn"},{"issue":"1","key":"R30-20230817","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"R31-20230817","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat Diagn"},{"issue":"2","key":"R32-20230817","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"R33-20230817","article-title":"Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA","author":"Grati","journal-title":"Genet Med"},{"issue":"1","key":"R34-20230817","first-page":"1","article-title":"Cell-free DNA screening for fetal aneuploidy","volume":"37","author":"Dugoff","year":"2017","journal-title":"Topics Ob Gyn"},{"issue":"1","key":"R35-20230817","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin Chem"},{"issue":"2","key":"R37-20230817","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cll.2016.01.015","article-title":"Cell-free DNA: comparison of technologies","volume":"36","author":"Dar","year":"2016","journal-title":"Clin Lab Med"},{"issue":"2","key":"R38-20230817","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/jcm3020537","article-title":"Non-invasive prenatal testing using cell free DNA in maternal plasma: recent developments and future prospects","volume":"3","author":"Benn","year":"2014","journal-title":"J Clin Med"},{"issue":"1","key":"R39-20230817","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1471-0528.14050","article-title":"The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis","volume":"124","author":"Mackie","year":"2017","journal-title":"BJOG"},{"issue":"8","key":"R40-20230817","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14737159.2018.1493924","article-title":"Next-generation sequencing and the impact on prenatal diagnosis","volume":"18","author":"Mellis","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"issue":"10173","key":"R41-20230817","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(18)31940-8","article-title":"Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study","volume":"393","author":"Lord","year":"2019","journal-title":"Lancet"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000654208.03441.23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T01:17:00Z","timestamp":1692321420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000654208.03441.23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000654208.03441.23","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}